Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 38,035 shares of the company’s stock, valued at approximately $647,000. Skandinaviska Enskilda Banken AB publ owned approximately 0.07% of Bicara Therapeutics as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Spire Wealth Management acquired a new stake in Bicara Therapeutics during the fourth quarter valued at approximately $31,000. SG Americas Securities LLC bought a new position in shares of Bicara Therapeutics during the 4th quarter worth approximately $147,000. Cinctive Capital Management LP acquired a new stake in Bicara Therapeutics in the 3rd quarter valued at $229,000. Barclays PLC bought a new stake in Bicara Therapeutics in the third quarter valued at $255,000. Finally, Jane Street Group LLC acquired a new position in Bicara Therapeutics during the third quarter worth $309,000.
Bicara Therapeutics Trading Up 8.7 %
Shares of BCAX stock opened at $13.50 on Tuesday. Bicara Therapeutics Inc. has a 1 year low of $11.10 and a 1 year high of $28.09. The business’s 50 day moving average is $13.15.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on BCAX
Bicara Therapeutics Company Profile
Bicara Therapeutics Inc, a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors.
Featured Stories
- Five stocks we like better than Bicara Therapeutics
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Can TikTok Stock Picks Really Make You Rich?
- How to Plot Fibonacci Price Inflection Levels
- The “Quality” Rotation: Back to Basics Investing
- How Investors Can Find the Best Cheap Dividend Stocks
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding BCAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report).
Receive News & Ratings for Bicara Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bicara Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.